ONCS
Price:
$0.2772
Market Cap:
$1.65M
OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-...[Read more]
Industry
Biotechnology
IPO Date
2010-04-07
Stock Exchange
NASDAQ
Ticker
ONCS
According to OncoSec Medical Incorporated’s latest financial reports and current stock price. The company's current ROE is 484.53%. This represents a change of 130.37% compared to the average of 210.33% of the last 4 quarters.
The mean historical ROE of OncoSec Medical Incorporated over the last ten years is -182.11%. The current 484.53% ROE has changed -366.06% with respect to the historical average. Over the past ten years (40 quarters), ONCS's ROE was at its highest in in the October 2022 quarter at 895.52%. The ROE was at its lowest in in the January 2020 quarter at -429.43%.
Average
-182.11%
Median
-137.79%
Minimum
-558.64%
Maximum
-31.55%
Discovering the peaks and valleys of OncoSec Medical Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 370.92%
Maximum Annual ROE = -31.55%
Minimum Annual Increase = -79.09%
Minimum Annual ROE = -558.64%
Year | ROE | Change |
---|---|---|
2022 | -558.64% | 370.92% |
2021 | -118.63% | -61.06% |
2020 | -304.63% | 144.29% |
2019 | -124.70% | -26.96% |
2018 | -170.72% | -14.87% |
2017 | -200.54% | 109.23% |
2016 | -95.85% | 47.52% |
2015 | -64.97% | 105.91% |
2014 | -31.55% | -79.09% |
2013 | -150.88% | 182.39% |
The current ROE of OncoSec Medical Incorporated (ONCS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-327.30%
5-year avg
-255.46%
10-year avg
-182.11%
OncoSec Medical Incorporated’s ROE is greater than ZyVersa Therapeutics, Inc. (-172.51%), greater than Palisade Bio, Inc. (-124.86%), less than Unicycive Therapeutics, Inc. (294.74%), greater than Apexigen, Inc. (-606.56%), greater than Immix Biopharma, Inc. (-86.48%), less than Phio Pharmaceuticals Corp. (0%), greater than 180 Life Sciences Corp. (-142.68%), less than Navidea Biopharmaceuticals, Inc. (3.04%), greater than First Wave BioPharma, Inc. (-63.06%), greater than Dermata Therapeutics, Inc. (-28.76%), greater than Revelation Biosciences, Inc. (-197.44%), greater than Panbela Therapeutics, Inc. (-243.91%), less than ContraFect Corporation (545.45%), less than Quoin Pharmaceuticals, Ltd. (403.13%), greater than Allarity Therapeutics, Inc. (-112.11%), greater than Kiromic BioPharma, Inc. (-704.78%), less than Virax Biolabs Group Limited (337.72%), greater than Biodexa Pharmaceuticals Plc (-115.10%), greater than null (-141.90%),
Company | ROE | Market cap |
---|---|---|
-172.51% | $2.70M | |
-124.86% | $4.25M | |
294.74% | $33.41M | |
-606.56% | $9.57M | |
-86.48% | $54.08M | |
0% | $2.25M | |
-142.68% | $1.89M | |
3.04% | $100.08K | |
-63.06% | $5.99M | |
-28.76% | $2.08M | |
-197.44% | $1.43M | |
-243.91% | $1.75M | |
545.45% | $1.72M | |
403.13% | $3.06M | |
-112.11% | $7.01M | |
-704.78% | $3.14M | |
337.72% | $15.24M | |
-115.10% | $105.64K | |
-141.90% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoSec Medical Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OncoSec Medical Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is OncoSec Medical Incorporated's ROE?
How is the ROE calculated for OncoSec Medical Incorporated (ONCS)?
What is the highest ROE for OncoSec Medical Incorporated (ONCS)?
What is the 3-year average ROE for OncoSec Medical Incorporated (ONCS)?
What is the 5-year average ROE for OncoSec Medical Incorporated (ONCS)?
How does the current ROE for OncoSec Medical Incorporated (ONCS) compare to its historical average?